JS Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
1WCM
CCA
JS Capital Management's RGEN Position: Q2 2021 in Review
JS Capital Management sold out of Repligen (RGEN) in Q2 2021, closing a stake of 2,500 shares — an estimated $486K sold.
JS Capital Management first reported a position in RGEN in Q2 2020 and held it in 2 quarters. The position peaked at $939K in Q2 2020. 429 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.
- JS Capital Management reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
- JS Capital Management sold 2,500 Repligen shares in Q2 2021, an estimated $486K.
- JS Capital Management first reported a position in Repligen in Q2 2020 and held it in 2 quarters.
- JS Capital Management's Repligen position peaked at $939K in Q2 2020.
- 429 funds tracked by Wall St. Rank held Repligen as of Q2 2021.
Based on JS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.